Clinical Trials

Clinical Trials

When new treatments for cancer are developed, they are tested through clinical trials in order to know whether they should be added to the standard treatment options offered to patients. The major advances in the treatment of gynecologic cancer have all been based on the results of clinical trials. Participation in trials allows patients access to cutting-edge treatment while helping to establish the standard of care for the next generation of women with these diseases.

Clinical Trials Videos for Patients

“Gynecologic Cancer Clinical Trials: What This Means for You,” is a video teaching tool for patients who might be interested in participating in gynecologic cancer clinical trials. This 19-minute program includes interviews with clinical trials patients describing their experiences as well as SGO member experts who debunk some of the misconceptions and myths surrounding clinical trials. This video was made possible by a generous grant from the GOG Foundation, Inc.

“Understanding Gynecologic Cancer Clinical Trials” is a useful resource for patients who might be considering a clinical trial. This four-minute animated video explains the main phases of clinical trials, as well as the possible differences between treatment arms.

Video files can be made available to providers who want to play this program in their waiting rooms. Contact Robyn Kurth, SGO Senior Communications Manager, for more information.

Clinical Trials Resources


Capitol Hill Fly-in Day increases awareness of clinical trials, research funding

(L to R) Patient advocate Dee Sparacio with Ginger Gardner, MD, during Capitol Hill Fly-in Day.

Twenty-two SGO Ambassadors and patient advocates “Hit the Hill” for the 2017 Capitol Hill Fly-in Day in Washington, DC, on Nov. 3, meeting with more than 60 Members of Congress’s Offices in one day. The participants provided general education on gynecologic cancers. The participants highlighted the importance of increased funding of gynecologic cancer clinical trials as well as the need for the preservation of the Ovarian Cancer Research Program (OCRP) at the Department of Defense, while establishing a personal connection for long-term relationships between Congress and the SGO.


SGO President Laurel W. Rice, MD, noted that the Capitol Hill visits are part of a multipronged approach focused on increasing the availability of, and enrollment in, clinical trials. This expanded platform includes:

  • Enhancing public/private partnerships in the research arena
  • Increasing communication efforts: Develop SGO’s voice for patients, physicians, advocates, US government (mandate) and philanthropy
  • Increasing advocacy efforts: Build a united advocacy platform with the ability to have a common voice around gynecologic oncology clinical trials
  • Increasing the pipeline of Junior Investigators committed to conducting clinical trials
  • Expanding the SGO’s Ambassador Program